A PMS of Jakavi® in Patients With Steroid-Refractory Graft-versus-Host Disease (SR-GvHD) in Korea
Clinical trial NCT05621733 · COMPLETED
Trial details
- NCT number
- NCT05621733
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2023-04-07
- Primary completion
- 2026-05-08
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.